Bolt Biotherapeutics, Inc.
BOLT
$4.61
-$0.03-0.54%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/12/2026
-
Zacks Investment Research
3/12/2026
-
The Fly
3/12/2026
-
Globe Newswire
2/24/2026
-
Globe Newswire
11/13/2025
-
SeekingAlpha.com: All News
11/12/2025
-
Zacks Investment Research
11/12/2025
-
GuruFocus
11/12/2025
-
TipRanks Financial Blog
11/12/2025
-
The Fly
11/12/2025
-
Globe Newswire
11/4/2025
-
Zacks Investment Research
10/20/2025
-
The Fly
10/2/2025
-
TipRanks Financial Blog
10/2/2025
-
FierceBiotech.com - Biotech
10/1/2025
-
GuruFocus
10/1/2025
-
The Fly
10/1/2025
-
Globe Newswire
9/3/2025
-
TipRanks Financial Blog
8/15/2025
-
The Fly
8/14/2025
-
Zacks Investment Research
8/14/2025
-
GuruFocus
8/14/2025
-
GuruFocus
8/14/2025
-
Fool.com Headlines
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 12, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 665 9295
Address
900 Chesapeake Drive
Redwood City, CA 94063
Redwood City, CA 94063
Country
Year Founded
Business Description
Sector
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies for the treatment of cancer. The company’s pipeline products include BDC-4182, a...
more